Aquyre Biosciences to present at this year’s Biotech Showcase | Data from Biopsies, 2-Minutes in the Operating Room
Weston, MA – Aquyre Biosciences, Inc. today announced that its CEO Bertrand de Poly, will be presenting at this year’s Biotech Showcase™. The presentation titled Data from Biopsies, 2-Minutes in the Operating Room will highlight the benefits of the CelTivity™ system and how it’s impacted proceduralists efficiency in the operating room by improving the diagnostic yield.
CelTivity is FDA Class 1 registered and is the only microscopic system on the market to provide physicians with a 2-minute, non-destructive biopsy assessment for both fine needle aspiration (FNA) and tissue. Powered by proprietary technologies, including Dynamic Cell Imaging™ (DCI), CelTivity analyzes the entire biopsy’s intracellular and metabolic activity and presents the data in a heatmap, making results easy to interpret. Unlike traditional methods, this does not require any cutting or staining meaning the same biopsy examined using CelTivity can be sent to final pathology for final diagnosis and next generation sequencing (NGS). The AI based analysis of proprietary data will further automate the results with features such as enhancing areas of interest, counting cancer cells and diagnosis.
The presentation will take place Tuesday, January 10, 2023 at 4:15pm PT. The presentation, in addition to being live, will be accessible through recording.
“I am thrilled to be participating in this year’s Biotech Showcase,” said Bertrand de Poly. “We have had an impressive year, hitting some very crucial milestones, and are looking forward to 2023 as we continue to provide proceduralists with access to real-time data in the operating room.”
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities.
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 15th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
About Aquyre Biosciences
Aquyre Biosciences, Inc is the creator of CelTivity™, the industry leader in two-minute lung biopsy adequacy assessment. Powered by two proprietary technologies including Dynamic Cell Imaging™ (DCI), CelTivity can scan a biopsy and measure intracellular and metabolic activity throughout extracted tissue. This activity is presented in a heatmap, making it easy to interpret. The assessment does not require any cutting or staining, meaning the same tissue assessed for adequacy can go to final pathology to review for cancer, granuloma, lymphocytes, and more. Aquyre Biosciences is headquartered out of Weston, Mass. For more information, please visit www.aquyre.com
